Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Regulation of AIF expression by p53.
Stambolsky P, Weisz L, Shats I, Klein Y, Goldfinger N, Oren M, Rotter V. Stambolsky P, et al. Among authors: rotter v. Cell Death Differ. 2006 Dec;13(12):2140-9. doi: 10.1038/sj.cdd.4401965. Epub 2006 May 26. Cell Death Differ. 2006. PMID: 16729031
Mutant p53 gain-of-function in cancer.
Oren M, Rotter V. Oren M, et al. Among authors: rotter v. Cold Spring Harb Perspect Biol. 2010 Feb;2(2):a001107. doi: 10.1101/cshperspect.a001107. Cold Spring Harb Perspect Biol. 2010. PMID: 20182618 Free PMC article. Review.
Modulation of the vitamin D3 response by cancer-associated mutant p53.
Stambolsky P, Tabach Y, Fontemaggi G, Weisz L, Maor-Aloni R, Siegfried Z, Shiff I, Kogan I, Shay M, Kalo E, Blandino G, Simon I, Oren M, Rotter V. Stambolsky P, et al. Among authors: rotter v. Cancer Cell. 2010 Mar 16;17(3):273-85. doi: 10.1016/j.ccr.2009.11.025. Cancer Cell. 2010. PMID: 20227041 Free PMC article.
p53, a novel regulator of lipid metabolism pathways.
Goldstein I, Ezra O, Rivlin N, Molchadsky A, Madar S, Goldfinger N, Rotter V. Goldstein I, et al. Among authors: rotter v. J Hepatol. 2012 Mar;56(3):656-62. doi: 10.1016/j.jhep.2011.08.022. Epub 2011 Oct 26. J Hepatol. 2012. PMID: 22037227 Free article.
Targeting mutant p53 for cancer therapy.
Oren M, Tal P, Rotter V. Oren M, et al. Among authors: rotter v. Aging (Albany NY). 2016 Jun;8(6):1159-60. doi: 10.18632/aging.100992. Aging (Albany NY). 2016. PMID: 27347904 Free PMC article. No abstract available.
Introduction: p53--the first twenty years.
Oren M, Rotter V. Oren M, et al. Among authors: rotter v. Cell Mol Life Sci. 1999 Jan;55(1):9-11. doi: 10.1007/s000180050265. Cell Mol Life Sci. 1999. PMID: 10065147 Review.
Transcription regulation by mutant p53.
Weisz L, Oren M, Rotter V. Weisz L, et al. Among authors: rotter v. Oncogene. 2007 Apr 2;26(15):2202-11. doi: 10.1038/sj.onc.1210294. Oncogene. 2007. PMID: 17401429 Review.
306 results